22 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33086879 | Fisetin Inhibits Autophagy in HepG2 Cells via PI3K/Akt/mTOR and AMPK Pathway. | 2021 | 3 |
2 | 34695518 | Fisetin-induced PTEN expression reverses cellular senescence by inhibiting the mTORC2-Akt Ser473 phosphorylation pathway in vascular smooth muscle cells. | 2021 Dec | 1 |
3 | 34821587 | Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling. | 2021 Nov 25 | 1 |
4 | 32257052 | RNA-seq data analysis of stimulated hepatocellular carcinoma cells treated with epigallocatechin gallate and fisetin reveals target genes and action mechanisms. | 2020 | 2 |
5 | 30431692 | Fisetin induces apoptosis in breast cancer MDA-MB-453 cells through degradation of HER2/neu and via the PI3K/Akt pathway. | 2019 Apr | 2 |
6 | 30468635 | Fisetin protects against rotenone-induced neurotoxicity through signaling pathway. | 2019 Jan 1 | 1 |
7 | 31540162 | Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. | 2019 Sep 15 | 3 |
8 | 29204750 | Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells. | 2018 Feb | 5 |
9 | 29574877 | Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. | 2018 Sep | 1 |
10 | 30108501 | Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway. | 2018 | 4 |
11 | 28204814 | Fisetin regulates astrocyte migration and proliferation in vitro. | 2017 Apr | 2 |
12 | 29296070 | Fisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression. | 2017 | 3 |
13 | 27158416 | Promising tumor inhibiting potentials of Fisetin through PI3K/AKT/mTOR pathway. | 2016 | 1 |
14 | 27551764 | Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways. | 2016 Oct | 2 |
15 | 27904686 | Fisetin, a dietary phytochemical, overcomes Erlotinib-resistance of lung adenocarcinoma cells through inhibition of MAPK and AKT pathways. | 2016 | 2 |
16 | 26590114 | Fisetin inhibits TNF-α-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression. | 2015 Dec | 2 |
17 | 24675012 | Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling. | 2014 Jun 1 | 2 |
18 | 23538677 | Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. | 2013 | 1 |
19 | 21618507 | Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. | 2012 Apr 1 | 3 |
20 | 19633975 | Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells. | 2010 Jan | 2 |
21 | 20530556 | Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. | 2010 Aug | 1 |
22 | 20637980 | Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin. | 2010 Aug 1 | 1 |